{"id":1804,"date":"2020-02-19T10:20:04","date_gmt":"2020-02-19T01:20:04","guid":{"rendered":"https:\/\/clarivate.com\/jp\/blog\/2020%e5%b9%b4%e4%b8%8a%e5%b8%82%e4%ba%88%e5%ae%9a%e3%81%ae%e6%96%b0%e8%96%ac%e3%81%ae%e3%81%86%e3%81%a1%e3%80%81%e6%82%a3%e8%80%85%e6%95%b0%e3%81%ae%e5%a4%9a%e3%81%84%e7%96%be%e7%97%85%e5%88%86\/?lang=ja"},"modified":"2020-02-19T10:20:04","modified_gmt":"2020-02-19T01:20:04","slug":"drugs-to-watch-2020","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ja\/blog\/drugs-to-watch-2020\/","title":{"rendered":"2020\u5e74\u4e0a\u5e02\u4e88\u5b9a\u306e\u65b0\u85ac\u306e\u3046\u3061\u3001\u60a3\u8005\u6570\u306e\u591a\u3044\u75be\u75c5\u5206\u91ce\u306b\u5e0c\u671b\u3092\u3082\u305f\u3089\u3059\u30d6\u30ed\u30c3\u30af\u30d0\u30b9\u30bf\u30fc\u5019\u88dc\u3068\u306a\u308b11\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u307e\u3068\u3081\u305f2020\u5e74\u7248Drugs to Watch\u3092\u30ea\u30ea\u30fc\u30b9"},"content":{"rendered":"

\u82f1\u8a9e\u539f\u6587<\/a><\/p>\n

 
\n <\/p>\n

Cortellis\u30c1\u30fc\u30e0\u306f\u3001\u4e73\u304c\u3093\u3001\u30ea\u30f3\u30d1\u816b\u3001\u591a\u767a\u6027\u786c\u5316\u75c7\uff08MS\uff09\u304a\u3088\u3073\u7247\u982d\u75db\u306e\u6cbb\u7642\u85ac\u3067\u3001\u5546\u696d\u7684\u30fb\u81e8\u5e8a\u7684\u306b\u6210\u529f\u3059\u308b\u65b0\u85ac\u3092\u4e88\u60f3\u3057\u307e\u3057\u305f\u3002<\/p>\n

2020<\/strong>\u5e74<\/strong>2<\/strong>\u6708<\/strong>10<\/strong>\u65e5\uff08\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2<\/strong> (<\/strong>\u7c73<\/strong>)<\/strong>\uff06\u30ed\u30f3\u30c9\u30f3<\/strong> (<\/strong>\u82f1<\/strong>)<\/strong>\uff09<\/strong><\/p>\n

\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3055\u305b\u308b\u4fe1\u983c\u6027\u306e\u9ad8\u3044\u77e5\u898b\u3068\u5206\u6790\u3092\u63d0\u4f9b\u3059\u308b\u4e16\u754c\u7684\u30ea\u30fc\u30c0\u30fc\u306e\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9plc\uff08NYSE:CCC; CCC.WS\uff09\u306f\u3001\u672c\u65e5\u3001\u6bce\u5e74\u6052\u4f8b\u306eCortellis\u300cDrugs to Watch\u300d\u306e\u30ea\u30ea\u30fc\u30b9\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u30022020\u5e74\u306b\u5e02\u5834\u53c2\u5165\u4e88\u5b9a\u306e\u65b0\u85ac\u306e\u3046\u3061\u30012024\u5e74\u307e\u3067\u306b\u5e74\u9593\u58f2\u4e0a\u984d10\u5104\u7c73\u30c9\u30eb\u8d85\uff08\u30d6\u30ed\u30c3\u30af\u30d0\u30b9\u30bf\u30fc\u3068\u307f\u306a\u3055\u308c\u308b\u6761\u4ef6\uff09\u306b\u9054\u3059\u308b\u3068\u60f3\u5b9a\u3055\u308c\u308b11\u306e\u533b\u85ac\u54c1\u3092\u7279\u5b9a\u3057\u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3057\u307e\u3057\u305f\u3002<\/p>\n

 <\/p>\n

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306eCortellis\u30c1\u30fc\u30e0\u306f\u3001\u72ec\u81ea\u306e\u6280\u8853\u3001\u30c4\u30fc\u30eb\u304a\u3088\u3073\u624b\u6cd5\u3092\u99c6\u4f7f\u3057\u3066\u30012020\u5e74\u521d\u982d\u306b\u30d5\u30a7\u30fc\u30baII\u8a66\u9a13\u4ee5\u964d\u306b\u9032\u3093\u3060\u533b\u85ac\u54c1\u306e\u4e2d\u304b\u3089\u3001\u672c\u30ea\u30b9\u30c8\u306b\u542b\u3081\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u533b\u85ac\u54c1\u306e\u30ea\u30b9\u30c8\u3092\u4f5c\u6210\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u5f8c\u3001\u793e\u5185\u30a2\u30ca\u30ea\u30b9\u30c8\u304c\u305d\u308c\u305e\u308c\u306e\u533b\u85ac\u54c1\u306b\u95a2\u3057\u3066\u500b\u5225\u306b\u3001\u5e74\u6b21\u5831\u544a\u66f8\u3001\u533b\u85ac\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u7279\u8a31\u3001\u5316\u5408\u7269\u3001\u4f01\u696d\u9593\u53d6\u5f15\u3001\u4f1a\u8b70\u3001\u4f01\u696d\u767a\u8868\u3001\u898f\u5236\u306e\u72b6\u6cc1\u306a\u3069\u306e\u8abf\u67fb\u3092\u8e0f\u307e\u3048\u3066\u7cbe\u67fb\u30fb\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u4eca\u5e74\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30cb\u30e5\u30fc\u30b9\u30b5\u30fc\u30d3\u30b9BioWorld<\/em>\u306e\u30a8\u30c7\u30a3\u30bf\u30fc\u304a\u3088\u3073\u30e9\u30a4\u30bf\u30fc\u304c\u3001\u69d8\u3005\u306a\u75be\u60a3\u306e\u72b6\u6cc1\u306b\u3064\u3044\u3066\u4fa1\u683c\u6226\u7565\u5206\u6790\u3084\u3001\u4e0a\u5e02\u306e\u5b9f\u73fe\u6027\u3092\u5224\u65ad\u3059\u308b\u4e0a\u3067\u6700\u3082\u91cd\u8981\u306a\u5224\u65ad\u57fa\u6e96\u3068\u306a\u308b\u30012020\u5e74\u306b\u5e02\u5834\u53c2\u5165\u3059\u308b\u305d\u306e\u65b0\u85ac\u304c\u60a3\u8005\u306a\u3089\u3073\u306b\u652f\u63f4\u30b0\u30eb\u30fc\u30d7\u304c\u6c42\u3081\u308b\u6069\u6075\u3092\u63d0\u4f9b\u3067\u304d\u308b\u304b\u3001\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u88cf\u4ed8\u3051\u3092\u78ba\u8a8d\u3059\u308b\u306a\u3069\u3001\u5168\u3066\u306e\u89d2\u5ea6\u304b\u3089\u8abf\u67fb\u3057\u307e\u3057\u305f\u3002<\/p>\n

 <\/p>\n

\u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u3068\u305d\u306e\u5206\u6790\u3067\u306f\u3001\u4e73\u304c\u3093\u3001\u591a\u767a\u6027\u786c\u5316\u75c7\uff08MS\uff09\u3001\u7247\u982d\u75db\u30012\u578b\u7cd6\u5c3f\u75c5\u306b\u5bfe\u3059\u308b\u533b\u85ac\u54c1\u3092\u542b\u3080\u3001\u6162\u6027\u3001\u9032\u884c\u6027\u3001\u305d\u3057\u3066\u3057\u3070\u3057\u3070\u8870\u5f31\u6027\u3067\u3042\u308b\u75be\u60a3\u304a\u3088\u3073\u75c7\u72b6\u306e\u6cbb\u7642\u3068\u6cbb\u7642\u6cd5\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u306f\u3001\u307b\u307c\u3059\u3079\u3066\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u307e\u305f\u306f\u5e02\u5834\u3078\u306e\u65e9\u671f\u5c0e\u5165\u3092\u76ee\u7684\u3068\u3057\u305f\u305d\u306e\u4ed6\u306e\u6307\u5b9a\u306b\u3088\u308a\u3001\u305d\u306e\u958b\u767a\u3092\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002\u30ea\u30b9\u30c8\u3055\u308c\u305f\u533b\u85ac\u54c1\u306e\u307b\u3068\u3093\u3069\u304c\u3001\u65e2\u306b\u7af6\u5408\u4ed6\u793e\u304c\u591a\u304f\u53c2\u5165\u3057\u3066\u3044\u308b\u5e02\u5834\u307e\u305f\u306f\u53c2\u5165\u3059\u308b\u614b\u52e2\u306b\u3042\u308b\u5e02\u5834\u306b\u3082\u95a2\u308f\u3089\u305a\u3001\u9ad8\u3044\u30ec\u30d9\u30eb\u3067\u306e\u5546\u696d\u7684\u6210\u529f\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u591a\u304f\u306e\u533b\u85ac\u54c1\u306f\u3001\u5b89\u5168\u6027\u306e\u9762\u3001\u7279\u306b\u5fc3\u81d3\u8840\u7ba1\u30ea\u30b9\u30af\u306b\u3064\u3044\u3066\u3001\u4ee3\u66ff\u7642\u6cd5\u3088\u308a\u3082\u5411\u4e0a\u3057\u3066\u3044\u308b\u70b9\u3092\u3068\u55a7\u4f1d\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u304c\u3001\u305d\u306e\u4ed6\u3001\u65b0\u3057\u3044\u4f5c\u7528\u6a5f\u5e8f\u307e\u305f\u306f\u6cbb\u7652\u306e\u53ef\u80fd\u6027\u3092\u5f37\u8abf\u3059\u308b\u3082\u306e\u3082\u3042\u308a\u307e\u3059\u3002<\/p>\n

 <\/p>\n

\u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u306e\u534a\u5206\u4ee5\u4e0a\u306f\u751f\u7269\u5b66\u7684\u88fd\u5264\u3067\u3042\u308a\u3001\u8fd1\u5e74\u6210\u9577\u3092\u7d9a\u3051\u3001\u898f\u5236\u5f53\u5c40\u3068\u4fdd\u967a\u8005\u304c\u5171\u306b\u30b3\u30b9\u30c8\u3092\u6291\u3048\u3088\u3046\u3068\u3057\u3066\u3044\u308b\u85ac\u4fa1\u304c\u4e0a\u6607\u50be\u5411\u306b\u3042\u308b\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u3059\u3002\u4eca\u5e74\u30ea\u30b9\u30c8\u3055\u308c\u305f\u8840\u53cb\u75c5A\u6cbb\u7642\u85ac\u306eValrox\uff08Biomarin Pharmaceutical, Inc.\uff09\u304a\u3088\u3073\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u6cbb\u7642\u85ac\u306elisocabtagene maraleucel\uff08Bristol-Myers Squibb Co\uff09\u306f\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u3068\u7d30\u80de\u6cbb\u7642\u3067\u3059\u304c\u3001\u3069\u3061\u3089\u3082\u8cbb\u7528\u304c\u9ad8\u3044\u3053\u3068\u3067\u7279\u306b\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u305f\u5834\u5408\u3001Valrox\u306f\u91cd\u5ea6\u306e\u8840\u53cb\u75c5A\u306b\u5bfe\u3059\u308b\u6700\u521d\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u76ee\u3055\u308c\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002Valrox\u306e\u5358\u56de\u6295\u4e0e\u6cbb\u7642\u306f\u3001\u75c7\u72b6\u306e\u6839\u672c\u8981\u56e0\u3067\u3042\u308b\u907a\u4f1d\u7684\u6b20\u9665\u3092\u4fee\u6b63\u3057\u3001\u8f38\u8840\u3068FVIII\u88dc\u5145\u7642\u6cd5\u306e\u5fc5\u8981\u6027\u3092\u6392\u9664\u3059\u308b\u3053\u3068\u306b\u306a\u308a\u9769\u65b0\u7684\u3067\u3059\u3002\u4e88\u60f3\u901a\u308a\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306e\u5730\u4f4d\u3092\u7372\u5f97\u3057\u305f\u5834\u5408\u3001\u6cbb\u7642\u3042\u305f\u308a250\u4e07\u30c9\u30eb\u304b\u3089300\u4e07\u30c9\u30eb\u306e\u30b3\u30b9\u30c8\u3068\u306a\u308a\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u6700\u3082\u9ad8\u4fa1\u306a\u533b\u85ac\u54c1\u306b\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n

 <\/p>\n

BioWorld\u306e\u30cb\u30e5\u30fc\u30b9\u30c7\u30a3\u30ec\u30af\u30bf\u30fcLynn Yoffee\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u533b\u5b66\u7814\u7a76\u3068\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u306e\u8ffd\u6c42\u304c\u52a0\u901f\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u79d1\u5b66\u7814\u7a76\u3001\u5546\u696d\u7684\u52d5\u6a5f\u3001\u516c\u5171\u8ca1\u306e\u9593\u3067\u7dca\u5f35\u304c\u7d9a\u3044\u3066\u3044\u307e\u3059\u304c\u3001\u3053\u306e\u533b\u85ac\u54c1\u304c\u63d0\u4f9b\u3055\u308c\u3001\u65b0\u3057\u3044\u4f5c\u7528\u6a5f\u5e8f\u306b\u3088\u308b\u6cbb\u7642\u306e\u53ef\u80fd\u6027\u304c\u63d0\u4f9b\u3055\u308c\u308c\u3070\u591a\u304f\u306e\u4eba\u3005\u306b\u5e0c\u671b\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002\u300d<\/p>\n

 <\/p>\n

\u5b8c\u5168\u7248\u306e\u30ea\u30b9\u30c8\u3068\u5404\u533b\u85ac\u54c1\u5206\u6790\u306f\u3001www.bioworld.com\/drugstowatch2020<\/a>\u304b\u3089\u7121\u6599\u3067\u5165\u624b\u53ef\u80fd\u3067\u3059\u3002<\/p>\n

 <\/p>\n

Cortellis Drugs to Watch 2020:<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u533b\u85ac\u54c1\u540d<\/strong><\/td>\n\u958b\u767a\u4f01\u696d<\/strong><\/td>\n\u75be\u75c5\u30fb\u75be\u60a3<\/strong><\/td>\n\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n\u6295\u4e0e\u65b9\u6cd5<\/strong><\/td>\n<\/tr>\n
Rimegepant<\/p>\n

(BHV-3000)<\/td>\n

Biohaven Pharmaceutical Holding Co. Ltd., of New Haven, Conn.<\/td>\nMigraine<\/td>\nCGRP antagonist<\/td>\nOral and buccal<\/td>\n<\/tr>\n
OMB-157<\/p>\n

(ofatumumab sc)<\/td>\n

Novartis AG, of Basel, Switzerland<\/td>\nMultiple sclerosis<\/td>\nAnti-CD20 (MAb)<\/td>\nSubcutaneous injection<\/td>\n<\/tr>\n
Ozanimod (RPC-1063)<\/td>\nCelgene Corp., of Summit, N.J. (subsidiary of Bristol-Myers Squibb)<\/td>\nMultiple sclerosis<\/td>\nS1P1 and S1P5 receptor agonist<\/td>\nOral<\/td>\n<\/tr>\n
Vadadustat<\/td>\nAkebia Therapeutics Inc., of Cambridge, Mass., Mitsubishi Tanabe Pharma America Inc., of Jersey City, N.J., Otsuka Pharmaceutical Co., of Tokyo<\/td>\nAnemia due to chronic kidney disease<\/td>\nHIF-PH inhibitor<\/td>\nOral<\/td>\n<\/tr>\n
Valrox<\/p>\n

(valoctocogene roxaparvovec; BMN-270)<\/td>\n

Biomarin Pharmaceutical Inc., of San Rafael, Calif.<\/td>\nHemophilia A<\/td>\nFVIII gene therapy (via AAV5 vector)<\/td>\nIntravenous infusion<\/td>\n<\/tr>\n
Filgotinib<\/p>\n

(GLPG-0634)<\/td>\n

Gilead Sciences Inc., of Foster City, Calif., NV, of Mechelen, Belgium<\/td>\nRheumatoid arthritis<\/td>\nJAK1 selective inhibitor<\/td>\nOral<\/td>\n<\/tr>\n
Rybelsus<\/p>\n

(semaglutide, oral, once daily)<\/td>\n

Novo Nordisk A\/S, of Bagsvaerd, Denmar<\/td>\nType 2 diabetes mellitus<\/td>\nLong-acting GLP-1 analog<\/td>\nOral<\/td>\n<\/tr>\n
Inclisiran<\/p>\n

(ALN-PCSsc; ALN-60212; PCSK9si)<\/td>\n

The Medicines Co., of Parsippany, N.J. (subsidiary of Novartis)<\/td>\nHypercholesterolemia<\/td>\nPCSK9 small interference RNA (siRNA)<\/td>\nSubcutaneous injection<\/td>\n<\/tr>\n
Sacituzumab govitecan<\/p>\n

(IMMU-132)<\/td>\n

Inc., of Morris Plains, N.J., Medicine Inc., of New York<\/td>\nMetastatic triple-negative breast cancer<\/td>\nAnti-TROP2-SN38 ADC<\/td>\nIntravenous infusion<\/td>\n<\/tr>\n
Enhertu<\/p>\n

(trastuzumab deruxtecan; DS-8201a)<\/td>\n

Daiichi Sankyo Co. Ltd., of Tokyo, Astrazeneca plc, Cambridge, U.K.<\/td>\nUnresectable or metastatic HER2-positive breast cancer<\/td>\nAnti-HER2-exatecan ADC<\/td>\nIntravenous infusion<\/td>\n<\/tr>\n
Liso-cel<\/p>\n

(JCAR-017; lisocabtagene maraleucel)<\/td>\n

Celgene, of Summit, N.J. (subsidiary of Bristol-Myers Squibb Co., of Princeton, N.J.)<\/td>\nLarge B-cell lymphoma<\/td>\nAnti-CD19 CAR T-cell therapy<\/td>\nIntravenous infusion<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/strong><\/p>\n

Cortellis Drugs to Watch 2020<\/strong>\u306e\u65b9\u6cd5\u8ad6<\/strong><\/p>\n

\u3053\u306e\u30ea\u30b9\u30c8\u306e\u30c7\u30fc\u30bf\u306f\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9 \u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u3042\u308bCortellis\u304b\u3089\u7de8\u96c6\u3055\u308c\u307e\u3057\u305f\u3002 Cortellis\u306b\u306f\u3001R\uff06D\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306b\u308f\u305f\u3063\u3066\u3001\u5e74\u6b21\u5831\u544a\u66f8\u3001\u533b\u85ac\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u7279\u8a31\u3001\u5316\u5408\u7269\u3001\u53d6\u5f15\u3001\u4f1a\u8b70\u3001\u4f01\u696d\u767a\u8868\u306a\u3069\u3001\u6700\u3082\u5e83\u304f\u3066\u6df1\u3044\u60c5\u5831\u6e90\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u30d5\u30a7\u30fc\u30ba2\u3001\u30d5\u30a7\u30fc\u30ba3\u3001\u627f\u8a8d\u7533\u8acb\u4e2d\u3001\u627f\u8a8d\u6e08\u307f\u3001\u307e\u305f\u306f2020\u5e74\u306e\u65e9\u3044\u6642\u671f\u306b\u767a\u58f2\u3055\u308c\u305f\u533b\u85ac\u54c1\u3092\u9078\u629e\u3057\u5206\u6790\u3057\u307e\u3057\u305f\u3002 2020\u5e74\u4ee5\u524d\u306b\u767a\u58f2\u3055\u308c\u305f\u533b\u85ac\u54c1\u306f\u9664\u5916\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u30012024\u5e74\u306b\u7dcf\u58f2\u4e0a\u984d\u304c10\u5104\u30c9\u30eb\u4ee5\u4e0a\u3068\u63a8\u7b97\u3055\u308c\u308b\u533b\u85ac\u54c1\u306b\u7d5e\u308a\u307e\u3057\u305f\u3002\u7d5e\u308a\u8fbc\u3093\u3060\u533b\u85ac\u54c1\u3092\u3001\u3055\u3089\u306b\u793e\u5185\u306e\u5c02\u9580\u5bb6\u3084\u30b3\u30f3\u30b5\u30eb\u30bf\u30f3\u30c8\u304c\u624b\u4f5c\u696d\u3067\u30ec\u30d3\u30e5\u30fc\u3057\u3001\u4e88\u60f3\u3055\u308c\u308b\u627f\u8a8d\u65e5\u307e\u305f\u306f\u767a\u58f2\u65e5\u306a\u3069\u306b\u57fa\u3065\u3044\u30662020\u5e74\u4e2d\u306e\u4e0a\u5e02\u53ef\u80fd\u6027\u3092\u5224\u65ad\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30de\u30cb\u30e5\u30a2\u30eb\u30ec\u30d3\u30e5\u30fc\u306b\u3088\u308a\u30012020\u5e74\u306b\u6ce8\u76ee\u3059\u3079\u304d11\u306e\u533b\u85ac\u54c1\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u5f8c\u3001\u5404\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u3001\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u3084\u898f\u5236\u72b6\u6cc1\u3001\u5404\u533b\u85ac\u54c1\u306e\u5e02\u5834\uff08\u7af6\u5408\u85ac\u306e\u5206\u6790\u3092\u542b\u3080\uff09\u304a\u3088\u3073\u85ac\u4e8b\u6307\u5b9a\uff08Orphan Drug\u3001Priority Review\u306a\u3069\uff09\u3092\u542b\u3080\u500b\u3005\u306e\u5185\u5bb9\u306b\u95a2\u3057\u3066\u8abf\u67fb\u304a\u3088\u3073\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002\u7528\u3044\u305f\u60c5\u5831\u6e90\u306b\u306f\u3001Cortellis\u30a8\u30c7\u30a3\u30bf\u30fc\u306b\u3088\u308bSWOT\u5206\u6790\u3001\u30d0\u30a4\u30aa\u88fd\u200b\u200b\u85ac\u4f1a\u793e\u306e\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\u3001\u305d\u306e\u4ed6\u306e\u51fa\u7248\u7269\uff08\u4f8b\uff1a\u5e74\u6b21\u5831\u544a\u66f8\uff09\u3001\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u3001Cortellis\u5185\u306e\u8ca9\u58f2\u30c7\u30fc\u30bf\uff08Refinitiv I \/ B \/ E \/ S\u304b\u3089\u4f9b\u7d66\uff09\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\uff08\u30c7\u30fc\u30bf\u62bd\u51fa\u65e52020\u5e741\u670820\u65e5\uff09<\/p>\n

 <\/p>\n

Cortellis<\/strong>\u306b\u3064\u3044\u3066<\/strong><\/p>\n

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306eCortellis™\u306f\u3001\u30c7\u30a3\u30b9\u30ab\u30d0\u30ea\u30fc\u6bb5\u968e\u304b\u3089\u81e8\u5e8a\u958b\u767a\u3001\u305d\u3057\u3066\u898f\u5236\u5f53\u5c40\u3078\u306e\u7533\u8acb\u627f\u8a8d\u3001\u5546\u54c1\u5316\u307e\u3067\u3001\u533b\u85ac\u54c1\u958b\u767a\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306b\u308f\u305f\u308b\u7591\u554f\u306b\u5bfe\u3057\u3066\u6b63\u78ba\u3067\u5b9f\u7528\u7684\u306a\u56de\u7b54\u3092\u53ef\u80fd\u306b\u3057\u3001\u30c7\u30fc\u30bf\u306e\u96a0\u308c\u305f\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u89e3\u304d\u653e\u3061\u3001\u30b5\u30a4\u30a8\u30f3\u30b9\u3092\u6b21\u306e\u30b9\u30c6\u30fc\u30b8\u3078\u3068\u9032\u3081\u307e\u3059\u3002\u30c7\u30fc\u30bf\u99c6\u52d5\u578b\u306e\u610f\u601d\u6c7a\u5b9a\u3092\u30b5\u30dd\u30fc\u30c8\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001Cortellis\u306f\u88fd\u85ac\u4f1a\u793e\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304a\u3088\u3073\u533b\u7642\u6a5f\u5668\/\u8a3a\u65ad\u4f01\u696d\u304c\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3059\u308b\u3053\u3068\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u307e\u3059\u3002<\/p>\n

 <\/p>\n

BioWorld<\/strong>\u306b\u3064\u3044\u3066<\/strong><\/p>\n

BioWorld\u306e\u30cb\u30e5\u30fc\u30b9\u30b5\u30fc\u30d3\u30b9\u30b9\u30a4\u30fc\u30c8\u306f\u3001\u958b\u767a\u4e2d\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u3068\u533b\u7642\u6280\u8853\u306b\u95a2\u3059\u308b\u5b9f\u7528\u7684\u306a\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u4e16\u754c\u4e2d\u306b\u30e9\u30a4\u30bf\u30fc\u3068\u30a8\u30c7\u30a3\u30bf\u30fc\u3092\u99d0\u5728\u3055\u305b\u3066\u3044\u308bBioWorld\u306f\u3001\u6700\u65b0\u30cb\u30e5\u30fc\u30b9\u3092\u914d\u4fe1\u3057\u3001\u958b\u767a\u4e2d\u306e\u6570\u767e\u306e\u6cbb\u7642\u85ac\u3068\u30c7\u30d0\u30a4\u30b9\u3001\u305d\u308c\u3089\u306e\u80cc\u5f8c\u306b\u3042\u308b\u4f01\u696d\u3001\u5e02\u5834\u3092\u9032\u5316\u3055\u305b\u308b\u30d3\u30b8\u30cd\u30b9\u958b\u767a\u30c8\u30e9\u30f3\u30b6\u30af\u30b7\u30e7\u30f3\u3001\u305d\u306e\u4e21\u65b9\u306b\u5bfe\u3059\u308b\u898f\u5236\u306e\u30cf\u30fc\u30c9\u30eb\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u8996\u70b9\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>\n

 <\/p>\n

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306b\u3064\u3044\u3066<\/strong><\/p>\n

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306f\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3059\u308b\u305f\u3081\u306b\u4fe1\u983c\u6027\u306e\u3042\u308b\u77e5\u898b\u3068\u5206\u6790\u3092\u63d0\u4f9b\u3059\u308b\u4e16\u754c\u7684\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u904e\u53bb150\u5e74\u306b\u308f\u305f\u308b\u4e8b\u696d\u7d99\u7d9a\u3092\u901a\u3058\u3066\u3001Web of Science™\u3001Cortellis™\u3001Derwent™\u3001CompuMark™\u3001 MarkMonitor™\u3001Techstreet™\u306a\u3069\u3001\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30fb\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u822c\u306b\u308f\u305f\u308a\u4fe1\u983c\u306e\u3042\u308b\u88fd\u54c1\u30d6\u30e9\u30f3\u30c9\u3092\u7bc9\u3044\u3066\u304d\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u88fd\u54c1\u306f\u79d1\u5b66\u3068\u5b66\u8853\u7814\u7a76\u3001\u7279\u8a31\u8abf\u67fb\u3068\u5de5\u696d\u898f\u683c\u3001\u5546\u6a19\u304a\u3088\u3073\u30c9\u30e1\u30a4\u30f3\u30d6\u30e9\u30f3\u30c9\u4fdd\u8b77\u3001\u88fd\u85ac\u304a\u3088\u3073\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306a\u3069\u306e\u5206\u91ce\u3067\u4eca\u65e5\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u307e\u3059\u3002<\/p>\n

 <\/p>\n

\u5c06\u6765\u306e\u898b\u901a\u3057\u306b\u95a2\u3059\u308b\u8a18\u8ff0\u306b\u3064\u3044\u3066<\/strong><\/p>\n

\u672c\u30ea\u30ea\u30fc\u30b9\u306a\u3089\u3073\u306b\u53e3\u982d\u306e\u8a18\u8ff0\u306b\u542b\u307e\u308c\u308b\u60c5\u5831\u306f\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306b\u95a2\u3059\u308b\u4e88\u6e2c\u3084\u5c06\u6765\u306e\u898b\u901a\u3057\u306b\u95a2\u3059\u308b\u8a18\u8ff0\u304c\u542b\u307e\u308c\u3066\u3044\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002\u5c06\u6765\u306e\u898b\u901a\u3057\u306b\u95a2\u3059\u308b\u8a18\u8ff0\u306f\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u304c\u4f5c\u6210\u6642\u70b9\u306b\u304a\u3044\u3066\u671f\u5f85\u3059\u308b\u3053\u3068\u3001\u3082\u3057\u304f\u306f\u5c06\u6765\u306e\u51fa\u6765\u4e8b\u306b\u3064\u3044\u3066\u306e\u4e88\u6e2c\u3092\u63d0\u4f9b\u3059\u308b\u3082\u306e\u3067\u3001\u671f\u5f85\u3055\u308c\u308b\u76f8\u4e57\u52b9\u679c\u3084\u305d\u306e\u4ed6\u306e\u5c06\u6765\u7684\u898b\u8fbc\u307f\u306b\u95a2\u3059\u308b\u8a18\u8ff0\u3092\u542b\u3093\u3067\u3044\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8a18\u8ff0\u306b\u306f\u3001\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306e\u7ba1\u8f44\u5916\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u5b9f\u969b\u306e\u7d50\u679c\u304c\u7269\u7406\u7684\u306b\u5927\u5e45\u306b\u5909\u308f\u308b\u53ef\u80fd\u6027\u306e\u3042\u308b\u30ea\u30b9\u30af\u3084\u4e0d\u78ba\u5b9a\u4e8b\u9805\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u306f\u3001\u65b0\u305f\u306a\u60c5\u5831\u3001\u5c06\u6765\u306e\u51fa\u6765\u4e8b\u3001\u305d\u306e\u4ed6\u306e\u7d50\u679c\u306e\u5982\u4f55\u3092\u554f\u308f\u305a\u3001\u3053\u3053\u306b\u793a\u3055\u308c\u305f\u8a18\u8ff0\u3092\u66f4\u65b0\u307e\u305f\u306f\u4fee\u6b63\u3059\u308b\u7fa9\u52d9\u306f\u4e00\u5207\u8ca0\u308f\u306a\u3044\u3082\u306e\u3068\u3057\u307e\u3059\u3002<\/p>\n

Clarivate\u3068\u305d\u306e\u30ed\u30b4\u3001\u304a\u3088\u3073\u3053\u3053\u3067\u4f7f\u7528\u3055\u308c\u3066\u3044\u308b\u4ed6\u306e\u3059\u3079\u3066\u306e\u5546\u6a19\u306f\u3001\u305d\u308c\u305e\u308c\u306e\u6240\u6709\u8005\u306e\u5546\u6a19\u3067\u3042\u308a\u3001\u30e9\u30a4\u30bb\u30f3\u30b9\u306b\u57fa\u3065\u3044\u3066\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

 <\/p>\n

\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Clarivate Analytics\u304c2020\u5e742\u670810\u65e5\u306b\u767a\u8868\u3057\u305f\u30cb\u30e5\u30fc\u30b9\u30ea\u30ea\u30fc\u30b9\u3092\u65e5\u672c\u8a9e\u306b\u7ffb\u8a33\u518d\u7de8\u96c6\uff08\u4e00\u90e8\u8ffd\u8a18\u3092\u542b\u3080\uff09\u3057\u305f\u3082\u306e\u3067\u3059\u3002\u82f1\u6587\u30cb\u30e5\u30fc\u30b9\u30ea\u30ea\u30fc\u30b9\u306f\u3001https:\/\/clarivate.com\/cortellis\/news\/drugs-to-watch-list-from-clarivate-identifies-11-new-blockbusters-forecasted-to-launch-in-2020\/<\/a>\u3092\u3054\u53c2\u7167\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u672c\u8cc7\u6599\u306e\u6b63\u5f0f\u8a00\u8a9e\u306f\u82f1\u8a9e\u3067\u3042\u308a\u3001\u305d\u306e\u5185\u5bb9\u30fb\u89e3\u91c8\u306b\u3064\u3044\u3066\u306f\u82f1\u8a9e\u304c\u512a\u5148\u3057\u307e\u3059\u3002<\/p>\n

 <\/p>\n

\u672c\u4ef6\u306b\u95a2\u3059\u308b\u554f\u3044\u5408\u308f\u305b\u5148<\/strong><\/p>\n

\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9\u30fb\u30b8\u30e3\u30d1\u30f3\u682a\u5f0f\u4f1a\u793e<\/p>\n

https:\/\/www.clarivate.jp\/<\/a><\/p>\n

TEL\uff1a03-4589-3100<\/p>\n

Email\uff1amarketing.jp@clarivate.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u82f1\u8a9e\u539f\u6587     Cortellis\u30c1\u30fc\u30e0\u306f\u3001\u4e73\u304c\u3093\u3001\u30ea\u30f3\u30d1\u816b\u3001\u591a\u767a\u6027\u786c\u5316\u75c7\uff08MS\uff09\u304a\u3088\u3073\u7247\u982d\u75db\u306e\u6cbb\u7642\u85ac\u3067\u3001\u5546\u696d\u7684\u30fb\u81e8\u5e8a\u7684\u306b\u6210\u529f\u3059\u308b\u65b0\u85ac\u3092\u4e88\u60f3\u3057\u307e\u3057\u305f\u3002 2020\u5e742\u670810\u65e5\uff08\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2 (\u7c73)\uff06\u30ed\u30f3\u30c9\u30f3 (\u82f1)\uff09 \u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u52a0\u901f\u3055\u305b\u308b\u4fe1\u983c\u6027\u306e\u9ad8\u3044\u77e5\u898b\u3068\u5206\u6790\u3092\u63d0\u4f9b\u3059\u308b\u4e16\u754c\u7684\u30ea\u30fc\u30c0\u30fc\u306e\u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u30fb\u30a2\u30ca\u30ea\u30c6\u30a3\u30af\u30b9plc\uff08NYSE:CCC; CCC.WS\uff09\u306f\u3001\u672c\u65e5\u3001\u6bce\u5e74\u6052\u4f8b\u306eCortellis\u300cDrugs to Watch\u300d\u306e\u30ea\u30ea\u30fc\u30b9\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u30022020\u5e74\u306b\u5e02\u5834\u53c2\u5165\u4e88\u5b9a\u306e\u65b0\u85ac\u306e\u3046\u3061\u30012024\u5e74\u307e\u3067\u306b\u5e74\u9593\u58f2\u4e0a\u984d10\u5104\u7c73\u30c9\u30eb\u8d85\uff08\u30d6\u30ed\u30c3\u30af\u30d0\u30b9\u30bf\u30fc\u3068\u307f\u306a\u3055\u308c\u308b\u6761\u4ef6\uff09\u306b\u9054\u3059\u308b\u3068\u60f3\u5b9a\u3055\u308c\u308b11\u306e\u533b\u85ac\u54c1\u3092\u7279\u5b9a\u3057\u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3057\u307e\u3057\u305f\u3002   \u30af\u30e9\u30ea\u30d9\u30a4\u30c8\u306eCortellis\u30c1\u30fc\u30e0\u306f\u3001\u72ec\u81ea\u306e\u6280\u8853\u3001\u30c4\u30fc\u30eb\u304a\u3088\u3073\u624b\u6cd5\u3092\u99c6\u4f7f\u3057\u3066\u30012020\u5e74\u521d\u982d\u306b\u30d5\u30a7\u30fc\u30baII\u8a66\u9a13\u4ee5\u964d\u306b\u9032\u3093\u3060\u533b\u85ac\u54c1\u306e\u4e2d\u304b\u3089\u3001\u672c\u30ea\u30b9\u30c8\u306b\u542b\u3081\u308b\u53ef\u80fd\u6027\u304c\u9ad8\u3044\u533b\u85ac\u54c1\u306e\u30ea\u30b9\u30c8\u3092\u4f5c\u6210\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u5f8c\u3001\u793e\u5185\u30a2\u30ca\u30ea\u30b9\u30c8\u304c\u305d\u308c\u305e\u308c\u306e\u533b\u85ac\u54c1\u306b\u95a2\u3057\u3066\u500b\u5225\u306b\u3001\u5e74\u6b21\u5831\u544a\u66f8\u3001\u533b\u85ac\u54c1\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3001\u81e8\u5e8a\u8a66\u9a13\u3001\u7279\u8a31\u3001\u5316\u5408\u7269\u3001\u4f01\u696d\u9593\u53d6\u5f15\u3001\u4f1a\u8b70\u3001\u4f01\u696d\u767a\u8868\u3001\u898f\u5236\u306e\u72b6\u6cc1\u306a\u3069\u306e\u8abf\u67fb\u3092\u8e0f\u307e\u3048\u3066\u7cbe\u67fb\u30fb\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002 \u4eca\u5e74\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30cb\u30e5\u30fc\u30b9\u30b5\u30fc\u30d3\u30b9BioWorld\u306e\u30a8\u30c7\u30a3\u30bf\u30fc\u304a\u3088\u3073\u30e9\u30a4\u30bf\u30fc\u304c\u3001\u69d8\u3005\u306a\u75be\u60a3\u306e\u72b6\u6cc1\u306b\u3064\u3044\u3066\u4fa1\u683c\u6226\u7565\u5206\u6790\u3084\u3001\u4e0a\u5e02\u306e\u5b9f\u73fe\u6027\u3092\u5224\u65ad\u3059\u308b\u4e0a\u3067\u6700\u3082\u91cd\u8981\u306a\u5224\u65ad\u57fa\u6e96\u3068\u306a\u308b\u30012020\u5e74\u306b\u5e02\u5834\u53c2\u5165\u3059\u308b\u305d\u306e\u65b0\u85ac\u304c\u60a3\u8005\u306a\u3089\u3073\u306b\u652f\u63f4\u30b0\u30eb\u30fc\u30d7\u304c\u6c42\u3081\u308b\u6069\u6075\u3092\u63d0\u4f9b\u3067\u304d\u308b\u304b\u3001\u306b\u95a2\u3059\u308b\u79d1\u5b66\u7684\u88cf\u4ed8\u3051\u3092\u78ba\u8a8d\u3059\u308b\u306a\u3069\u3001\u5168\u3066\u306e\u89d2\u5ea6\u304b\u3089\u8abf\u67fb\u3057\u307e\u3057\u305f\u3002   \u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u3068\u305d\u306e\u5206\u6790\u3067\u306f\u3001\u4e73\u304c\u3093\u3001\u591a\u767a\u6027\u786c\u5316\u75c7\uff08MS\uff09\u3001\u7247\u982d\u75db\u30012\u578b\u7cd6\u5c3f\u75c5\u306b\u5bfe\u3059\u308b\u533b\u85ac\u54c1\u3092\u542b\u3080\u3001\u6162\u6027\u3001\u9032\u884c\u6027\u3001\u305d\u3057\u3066\u3057\u3070\u3057\u3070\u8870\u5f31\u6027\u3067\u3042\u308b\u75be\u60a3\u304a\u3088\u3073\u75c7\u72b6\u306e\u6cbb\u7642\u3068\u6cbb\u7642\u6cd5\u306b\u7126\u70b9\u3092\u5f53\u3066\u3066\u3044\u307e\u3059\u3002 \u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u306f\u3001\u307b\u307c\u3059\u3079\u3066\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u307e\u305f\u306f\u5e02\u5834\u3078\u306e\u65e9\u671f\u5c0e\u5165\u3092\u76ee\u7684\u3068\u3057\u305f\u305d\u306e\u4ed6\u306e\u6307\u5b9a\u306b\u3088\u308a\u3001\u305d\u306e\u958b\u767a\u3092\u52a0\u901f\u3057\u3066\u3044\u307e\u3059\u3002\u30ea\u30b9\u30c8\u3055\u308c\u305f\u533b\u85ac\u54c1\u306e\u307b\u3068\u3093\u3069\u304c\u3001\u65e2\u306b\u7af6\u5408\u4ed6\u793e\u304c\u591a\u304f\u53c2\u5165\u3057\u3066\u3044\u308b\u5e02\u5834\u307e\u305f\u306f\u53c2\u5165\u3059\u308b\u614b\u52e2\u306b\u3042\u308b\u5e02\u5834\u306b\u3082\u95a2\u308f\u3089\u305a\u3001\u9ad8\u3044\u30ec\u30d9\u30eb\u3067\u306e\u5546\u696d\u7684\u6210\u529f\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u591a\u304f\u306e\u533b\u85ac\u54c1\u306f\u3001\u5b89\u5168\u6027\u306e\u9762\u3001\u7279\u306b\u5fc3\u81d3\u8840\u7ba1\u30ea\u30b9\u30af\u306b\u3064\u3044\u3066\u3001\u4ee3\u66ff\u7642\u6cd5\u3088\u308a\u3082\u5411\u4e0a\u3057\u3066\u3044\u308b\u70b9\u3092\u3068\u55a7\u4f1d\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u304c\u3001\u305d\u306e\u4ed6\u3001\u65b0\u3057\u3044\u4f5c\u7528\u6a5f\u5e8f\u307e\u305f\u306f\u6cbb\u7652\u306e\u53ef\u80fd\u6027\u3092\u5f37\u8abf\u3059\u308b\u3082\u306e\u3082\u3042\u308a\u307e\u3059\u3002   \u30ea\u30b9\u30c8\u30a2\u30c3\u30d7\u3055\u308c\u305f\u533b\u85ac\u54c1\u306e\u534a\u5206\u4ee5\u4e0a\u306f\u751f\u7269\u5b66\u7684\u88fd\u5264\u3067\u3042\u308a\u3001\u8fd1\u5e74\u6210\u9577\u3092\u7d9a\u3051\u3001\u898f\u5236\u5f53\u5c40\u3068\u4fdd\u967a\u8005\u304c\u5171\u306b\u30b3\u30b9\u30c8\u3092\u6291\u3048\u3088\u3046\u3068\u3057\u3066\u3044\u308b\u85ac\u4fa1\u304c\u4e0a\u6607\u50be\u5411\u306b\u3042\u308b\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u3059\u3002\u4eca\u5e74\u30ea\u30b9\u30c8\u3055\u308c\u305f\u8840\u53cb\u75c5A\u6cbb\u7642\u85ac\u306eValrox\uff08Biomarin Pharmaceutical, Inc.\uff09\u304a\u3088\u3073\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u6cbb\u7642\u85ac\u306elisocabtagene maraleucel\uff08Bristol-Myers Squibb Co\uff09\u306f\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u3068\u7d30\u80de\u6cbb\u7642\u3067\u3059\u304c\u3001\u3069\u3061\u3089\u3082\u8cbb\u7528\u304c\u9ad8\u3044\u3053\u3068\u3067\u7279\u306b\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u305f\u5834\u5408\u3001Valrox\u306f\u91cd\u5ea6\u306e\u8840\u53cb\u75c5A\u306b\u5bfe\u3059\u308b\u6700\u521d\u306e\u6f5c\u5728\u7684\u306a\u6cbb\u7642\u30a2\u30d7\u30ed\u30fc\u30c1\u3068\u76ee\u3055\u308c\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002Valrox\u306e\u5358\u56de\u6295\u4e0e\u6cbb\u7642\u306f\u3001\u75c7\u72b6\u306e\u6839\u672c\u8981\u56e0\u3067\u3042\u308b\u907a\u4f1d\u7684\u6b20\u9665\u3092\u4fee\u6b63\u3057\u3001\u8f38\u8840\u3068FVIII\u88dc\u5145\u7642\u6cd5\u306e\u5fc5\u8981\u6027\u3092\u6392\u9664\u3059\u308b\u3053\u3068\u306b\u306a\u308a\u9769\u65b0\u7684\u3067\u3059\u3002\u4e88\u60f3\u901a\u308a\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306e\u5730\u4f4d\u3092\u7372\u5f97\u3057\u305f\u5834\u5408\u3001\u6cbb\u7642\u3042\u305f\u308a250\u4e07\u30c9\u30eb\u304b\u3089300\u4e07\u30c9\u30eb\u306e\u30b3\u30b9\u30c8\u3068\u306a\u308a\u3001\u5e02\u5834\u306b\u304a\u3051\u308b\u6700\u3082\u9ad8\u4fa1\u306a\u533b\u85ac\u54c1\u306b\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002   BioWorld\u306e\u30cb\u30e5\u30fc\u30b9\u30c7\u30a3\u30ec\u30af\u30bf\u30fcLynn Yoffee\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u533b\u5b66\u7814\u7a76\u3068\u9769\u65b0\u7684\u306a\u533b\u85ac\u54c1\u306e\u8ffd\u6c42\u304c\u52a0\u901f\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u79d1\u5b66\u7814\u7a76\u3001\u5546\u696d\u7684\u52d5\u6a5f\u3001\u516c\u5171\u8ca1\u306e\u9593\u3067\u7dca\u5f35\u304c\u7d9a\u3044\u3066\u3044\u307e\u3059\u304c\u3001\u3053\u306e\u533b\u85ac\u54c1\u304c\u63d0\u4f9b\u3055\u308c\u3001\u65b0\u3057\u3044\u4f5c\u7528\u6a5f\u5e8f\u306b\u3088\u308b\u6cbb\u7642\u306e\u53ef\u80fd\u6027\u304c\u63d0\u4f9b\u3055\u308c\u308c\u3070\u591a\u304f\u306e\u4eba\u3005\u306b\u5e0c\u671b\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002\u300d   \u5b8c\u5168\u7248\u306e\u30ea\u30b9\u30c8\u3068\u5404\u533b\u85ac\u54c1\u5206\u6790\u306f\u3001www.bioworld.com\/drugstowatch2020\u304b\u3089\u7121\u6599\u3067\u5165\u624b\u53ef\u80fd\u3067\u3059\u3002  …<\/p>\n","protected":false},"author":2,"featured_media":1805,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[1071,1073],"tags":[1075],"class_list":["post-1804","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-cortellis","tag-life-sciences"],"acf":[],"lang":"ja","translations":{"ja":1804},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/1804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=1804"}],"version-history":[{"count":0,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/1804\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/1805"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=1804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=1804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=1804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}